Results Snapshot
Figures in Million
Consolidate Annual Results
Nov'24
Nov'23
Nov'22
Nov'21
Nov'20
Nov'19
Nov'18
Net Sales
117.06
110.47
103.69
87.55
88.81
84.01
58.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
117.06
110.47
103.69
87.55
88.81
84.01
58.55
Raw Material Cost
29.84
31.01
47.03
33.71
40.73
37.86
19.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
19.05
41.72
35.70
17.53
13.71
9.09
6.96
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.35
14.06
8.46
7.14
7.26
6.68
3.34
Selling and Distribution Expenses
52.28
50.14
60.51
50.02
47.99
43.06
33.25
Other Expenses
-0.97
-1.40
0.41
1.11
0.37
-0.14
0.00
Total Expenditure (Excl Depreciation)
105.77
122.90
155.79
119.53
113.35
95.33
63.09
Operating Profit (PBDIT) excl Other Income
11.299999999999999
-12.4
-52.1
-32
-24.5
-11.299999999999999
-4.5
Other Income
1.97
0.82
-0.92
-0.92
0.96
1.40
0.57
Operating Profit (PBDIT)
17.03
-7.13
-36.87
-21.94
-12.12
0.05
1.54
Interest
14.35
14.06
8.46
7.14
7.26
6.68
3.34
Exceptional Items
-9.78
-6.86
0.46
0.00
-0.01
-0.01
-0.37
Gross Profit (PBDT)
87.22
79.46
56.66
53.83
48.08
46.15
39.04
Depreciation
3.76
4.48
16.15
10.97
11.45
9.96
5.51
Profit Before Tax
-10.86
-32.53
-61.02
-40.05
-30.85
-16.61
-7.67
Tax
0.46
-0.16
0.16
-0.27
-0.38
0.00
-1.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-11.32
-32.37
-61.18
-39.78
-30.47
-16.61
-6.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-11.32
-32.37
-61.18
-39.78
-30.47
-16.61
-6.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-11.32
-32.37
-61.18
-39.78
-30.47
-16.61
-6.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
-35.38
-28.30
-30.60
22.78
4.18
32.99
46.54
Earnings per share (EPS)
-0.23
-1.23
-2.57
-1.72
-1.58
-0.86
-0.32
Diluted Earnings per share
-0.23
-1.23
-2.57
-1.72
-1.58
-0.86
-0.32
Operating Profit Margin (Excl OI)
9.64%
-11.26%
-50.24%
-36.54%
-27.63%
-13.47%
-7.75%
Gross Profit Margin
-6.06%
-25.39%
-43.27%
-33.21%
-21.84%
-7.91%
-3.7%
PAT Margin
-9.67%
-29.3%
-59.0%
-45.44%
-34.32%
-19.77%
-10.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Nov 2024 is 5.97% vs 6.56% in Nov 2023
Consolidate Net Profit
YoY Growth in year ended Nov 2024 is 65.12% vs 47.06% in Nov 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Nov 2024 is 288.75% vs 77.72% in Nov 2023
Interest
YoY Growth in year ended Nov 2024 is 1.42% vs 65.88% in Nov 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Nov 2024 has improved from Nov 2023
Compare Annual Results Of Theratechnologies, Inc. With
Figures in Million
Consolidate Annual Results
Change(CAD)
Change(%)
Net Sales
117.06
150.68
-33.62
-22.31%
Other Operating Income
0.00
0.00
0.00
Total Operating income
117.06
150.68
-33.62
-22.31%
Raw Material Cost
29.84
73.58
-43.74
-59.45%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
19.05
34.49
-15.44
-44.77%
Power Cost
0
0
0.00
Manufacturing Expenses
14.35
7.95
6.40
80.50%
Selling and Distribution Expenses
52.28
60.06
-7.78
-12.95%
Other Expenses
-0.97
-4.07
3.10
76.17%
Total Expenditure (Excl Depreciation)
105.77
135.35
-29.58
-21.85%
Operating Profit (PBDIT) excl Other Income
11.29
15.33
-4.04
-26.35%
Other Income
1.97
-1.49
3.46
232.21%
Operating Profit (PBDIT)
17.03
23.83
-6.80
-28.54%
Interest
14.35
7.95
6.40
80.50%
Exceptional Items
-9.78
-3.90
-5.88
-150.77%
Gross Profit (PBDT)
87.22
77.11
10.11
13.11%
Depreciation
3.76
9.98
-6.22
-62.32%
Profit Before Tax
-10.86
2.00
-12.86
-643.00%
Tax
0.46
-1.12
1.58
141.07%
Provisions and contingencies
0
0
0.00
Profit After Tax
-11.32
3.13
-14.45
-461.66%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-11.32
3.13
-14.45
-461.66%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-11.32
3.13
-14.45
-461.66%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
-35.38
75.05
-110.43
-147.14%
Earnings per share (EPS)
-0.23
0.12
-0.35
-291.67%
Diluted Earnings per share
-0.23
0.12
-0.35
-291.67%
Operating Profit Margin (Excl OI)
9.64%
10.18%
0.00
-0.54%
Gross Profit Margin
-6.06%
7.96%
0.00
-14.02%
PAT Margin
-9.67%
2.07%
0.00
-11.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 11.71 Million
in Nov 2024Figures in Million
YoY Growth in year ended Nov 2024 is 5.97% vs 6.56% in Nov 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -1.13 Million
in Nov 2024Figures in Million
YoY Growth in year ended Nov 2024 is 65.12% vs 47.06% in Nov 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.51 Million
in Nov 2024Figures in Million
YoY Growth in year ended Nov 2024 is 288.75% vs 77.72% in Nov 2023
Annual - Interest
Interest 1.43 Million
in Nov 2024Figures in Million
YoY Growth in year ended Nov 2024 is 1.42% vs 65.88% in Nov 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.64%
in Nov 2024Figures in %
YoY Growth in year ended Nov 2024 has improved from Nov 2023






